DIRECT new treatments for diabetic retinopathy.
Publication
, Journal Article
Mitchell, P; Wong, TY
Published in: Lancet
October 18, 2008
Duke Scholars
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 18, 2008
Volume
372
Issue
9647
Start / End Page
1361 / 1363
Location
England
Related Subject Headings
- Tetrazoles
- Randomized Controlled Trials as Topic
- Multicenter Studies as Topic
- Humans
- General & Internal Medicine
- Diabetic Retinopathy
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
- Blood Pressure
- Biphenyl Compounds
Citation
APA
Chicago
ICMJE
MLA
NLM
Mitchell, P., & Wong, T. Y. (2008). DIRECT new treatments for diabetic retinopathy. Lancet, 372(9647), 1361–1363. https://doi.org/10.1016/S0140-6736(08)61413-0
Mitchell, Paul, and Tien Y. Wong. “DIRECT new treatments for diabetic retinopathy.” Lancet 372, no. 9647 (October 18, 2008): 1361–63. https://doi.org/10.1016/S0140-6736(08)61413-0.
Mitchell P, Wong TY. DIRECT new treatments for diabetic retinopathy. Lancet. 2008 Oct 18;372(9647):1361–3.
Mitchell, Paul, and Tien Y. Wong. “DIRECT new treatments for diabetic retinopathy.” Lancet, vol. 372, no. 9647, Oct. 2008, pp. 1361–63. Pubmed, doi:10.1016/S0140-6736(08)61413-0.
Mitchell P, Wong TY. DIRECT new treatments for diabetic retinopathy. Lancet. 2008 Oct 18;372(9647):1361–1363.
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 18, 2008
Volume
372
Issue
9647
Start / End Page
1361 / 1363
Location
England
Related Subject Headings
- Tetrazoles
- Randomized Controlled Trials as Topic
- Multicenter Studies as Topic
- Humans
- General & Internal Medicine
- Diabetic Retinopathy
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
- Blood Pressure
- Biphenyl Compounds